Oct-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has demonstrated a consistent performance in the Arizona market, particularly in the Tincture & Sublingual category. Over the months from July to October 2024, the brand maintained a steady rank of 2nd place, indicating strong consumer loyalty and market presence. This stability is complemented by a positive sales trend, with October sales reaching a notable increase compared to previous months. Such consistency in ranking and sales growth suggests a robust strategy in product offerings and market engagement in this category. However, a comprehensive view of their performance across other states and categories could reveal more about their overall market strategy and adaptability.
In the Topical category within Arizona, Chronic Health has shown promising upward movement, climbing from 4th to 3rd place in September before settling back to 4th in October. This fluctuation, coupled with a steady increase in sales, suggests a dynamic competitive landscape where Chronic Health is actively vying for a higher market position. The brand's ability to maintain a top 4 ranking consistently is commendable, though not appearing in the top 30 in other states or categories could indicate areas needing strategic focus or improvement. The absence from top rankings outside of Arizona could either signal untapped potential or challenges in expanding their market footprint beyond this state.
Competitive Landscape
In the competitive landscape of the Topical category in Arizona, Chronic Health has shown a consistent performance, maintaining a stable rank over the past few months. In July 2024, Chronic Health was ranked 4th, and despite a brief climb to 3rd place in September, it returned to the 4th position by October. This indicates a resilient market presence amidst fluctuating sales figures. Notably, iLava, the leading brand, experienced a decline from the top spot to 2nd place in October, which could present an opportunity for Chronic Health to capture more market share. Meanwhile, Tru Infusion has shown strong upward momentum, overtaking Chronic Health in September and maintaining a higher rank. This competitive pressure highlights the need for Chronic Health to innovate or enhance its offerings to climb the ranks. Additionally, Müv / MUV and Gramz remain consistent competitors, with Müv / MUV slightly improving its sales in October, suggesting a competitive edge that Chronic Health must address to sustain its market position.
Notable Products
In October 2024, Chronic Health's top-performing product was the CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) in the Tincture & Sublingual category, maintaining its number one ranking from September with sales reaching 533 units. The CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) fell to second place after consistently holding the top rank from July to August. The Indica THC Glycerin Tincture (100mg THC, 1oz) remained stable in third place since July, showing steady sales growth. Pain Relief Ointment (90mg) held its fourth position throughout the past four months, while the CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC) slipped from second in August to fifth in October. These shifts highlight a strong preference for tinctures in the market, with topicals maintaining a consistent performance.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.